MIRM FY 2020 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$623,000

Operating Income

-$104M

Net Income

-$103M

EPS (Diluted)

$-4.09

Cash Flow

Operating Cash Flow

-$89M

Free Cash Flow

-$89M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$241M

Total Liabilities

$69M

Stockholders' Equity

$172M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$623,000	-$324,000	-92.3%
Operating Income	-$104M	-$55M	-90.5%
Net Income	-$103M	-$53M	-96.5%